ABans Enterprises Limited (BSE:512165) agreed to acquire Lifesurge Biosciences Private Limited from Abhishek Bansal and Shriyam Bansal for INR 0.1 million on December 13, 2019. The consideration shall be paid in cash. ABans Enterprises shall acquire 0.01 million shares of Lifesurge Biosciences. For the financial year 2018-2019, Lifesurge Biosciences reported turnover of INR 5.4 million and net loss of INR 36.1 million. Board of Directors of ABans Enterprises Limited approved the transaction at the meeting held on December 13, 2019. The transaction shall be completed before March 31, 2020. The Board of ABans Enterprises Limited believes acquisition will be accretive to its shareholders. ABans Enterprises Limited (BSE:512165) completed the acquisition of Lifesurge Biosciences Private Limited from Abhishek Bansal and Shriyam Bansal on January 1, 2020. LifeSurge BioSciences Private Limited has become wholly-owned subsidiary of ABans Enterprises Limited.